Alexander Y Tokman insider trades
Open-market stock purchases and sales by Alexander Y Tokman, Chief Executive Officer at ENDRA Life Sciences Inc, from SEC Form 4 filings since Apr 26, 2010.
Track record: 72% of 29 scored buys are up 5% or more since purchase, averaging +37%.